FIP Montreal 2026: Drug Delivery and Manufacturing

August 2026 in “ Pharmacy Education ”

Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

We don't know much about this study yet.

Read the full study on pharmacyeducation.fip.org →

Discuss this study in the Community →

Similar research 5

A Microfluidic Application for Mass Production of Drug-Loaded Polymeric Microspheres for a Long-Acting Injectable With IVL-DrugFluidic, a Novel Microfluidic Microsphere Manufacturing Platform Technology OpenNano · 2023
An Industry Update: What's New in the Field of Therapeutic Delivery This Month? Therapeutic Delivery · 2016
Drug Delivery Applications of Three-Dimensional Printed Mesoporous Scaffolds Pharmaceutics · 2020
Bridging the Organoid Translational Gap: Integrating Standardization and Micropatterning for Drug Screening in Clinical and Pharmaceutical Medicine Life Medicine · 2024
Design and Synthesis of Potential Nano-Carrier for Delivery of Diphencyprone to Hair Follicle Journal of Pharmaceutical Investigation · 2021

Related Community Posts Join

6 / 1000+ results

community Kintors interim report from 9-2-24 for everyone whos interested

32 upvotes 2 years ago

Kintor plans to release pyrilutamide foam and a plant-based Koshine by year-end, with GT20029 progressing in their pipeline. Users are pleased about the absence of propylene glycol (PG) in the new products.

community PP405 (Non) Update - Feb 2025

36 upvotes 1 year ago

The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.

community US FDA will now default to only one clinical trial for drug applications, will this accelerate the release of PP405 and other drugs in clinical trials?

13 upvotes 7 months ago

The FDA will now require only one clinical trial for drug approval, potentially speeding up the release of hair loss treatments like PP405. Pelage is expected to present full results of PP405 Phase 2a trials and move to Phase III in mid-2026.

community Update on Amplifica (new drugs) and Engraft (new hair transplant technology)

65 upvotes 2 months ago

Amplifica is developing new molecules for hair growth, with clinical trials expected soon, while Engraft Technologies is improving FUE robotic technology to make hair transplants faster and cheaper. Users express interest in the timeline for AMP-303 and concerns about high costs and effectiveness of current treatments.

community Hope Medicine's HMI-115 could be out in 2027 per Company Founder

34 upvotes 1 year ago

Hope Medicine's HMI-115 is expected to be released in 2027, with phase 3 trials currently recruiting. Concerns include the safety of targeting prolactin and the potential cost of the treatment.

community When will FAK Inhibitors / Standford Hydrogel be on the market for hair transplants?

9 upvotes 8 months ago

The conversation discusses the delay in bringing FAK inhibitors and Stanford's hydrogel to market for hair transplants, with a preference for FAK inhibitors over Verteporfin due to their superior potential in preventing scarring. The user expresses frustration over the slow progress and hopes for faster development by companies like FAKnostics.